Clarifying the decision rules and implementation boundaries for risk-based HCC surveillance in MASLD
Authors:
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver diseaseGut, 2025
- AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinomaHepatology, 2023
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 updateJournal of Hepatology, 2021
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018